We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+14.4%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$61.1M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.14M |
| 2 |
Broadcom
AVGO
|
+$3.01M |
| 3 |
Tesla
TSLA
|
+$2.23M |
| 4 |
Twist Bioscience
TWST
|
+$1.76M |
| 5 |
Novavax
NVAX
|
+$1.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$26.2M |
| 2 |
Danaher
DHR
|
+$17.1M |
| 3 |
Amgen
AMGN
|
+$12.4M |
| 4 |
Gilead Sciences
GILD
|
+$9.52M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$7.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
1076
Tvardi Therapeutics
TVRD
$23.5M
| $59.3K | ﹤0.01% |
+336
| New | +$113K |
|
1077
Companhia Siderúrgica Nacional
SID
$1.43B
| $57.7K | ﹤0.01% |
18,779
-1,150
| -6% | -$3.71K |
|
1078
Gaotu Techedu
GOTU
$372M
| $56.7K | ﹤0.01% |
+13,434
| New | +$52.3K |
|
1079
Santander
BSBR
$39.7B
| $56.4K | ﹤0.01% |
10,619
-574
| -5% | -$3.11K |
|
|
BDN
1080
Brandywine Realty Trust
BDN
$551M
| $55.6K | ﹤0.01% |
11,745
-1,741
| -13% | -$10.2K |
|
|
UNIT
1081
Uniti Group
UNIT
$2.63B
| $54.1K | ﹤0.01% |
15,246
-1,777
| -10% | -$9.43K |
|
|
ESPR
1082
DELISTED
Esperion Therapeutics
ESPR
| $48.6K | ﹤0.01% |
+30,581
| New | +$158K |
|
1083
Pitney Bowes
PBI
$2.42B
| $44.1K | ﹤0.01% |
11,330
-1,703
| -13% | -$7.15K |
|
|
TIGR
1084
UP Fintech Holding
TIGR
$845M
| $43.2K | ﹤0.01% |
+12,968
| New | +$47.8K |
|
|
CAN
1085
Canaan Creative
CAN
$176M
| $32.9K | ﹤0.01% |
12,198
-7,917
| -39% | -$22.6K |
|
1086
Globalstar
GSAT
$10.2B
| $15.4K | ﹤0.01% |
886
-1,023
| -54% | -$18.9K |
|
1087
Nektar Therapeutics
NKTR
$2.39B
| $8.37K | ﹤0.01% |
794
-89
| -10% | -$2.69K |
|
|
LOGC
1088
DELISTED
ContextLogic
LOGC
| $5.01K | ﹤0.01% |
375
-85
| -18% | -$1.45K |
|
|
BINI
1089
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
1090
American Airlines Group
AAL
$9.58B
| – | – |
-10,384
| Closed | -$132K |
|
1091
Affiliated Managers Group
AMG
$9.46B
| – | – |
-1,492
| Closed | -$236K |
|
|
AMTD
1092
AMTD IDEA Group
AMTD
$75.7M
| – | – |
-58,386
| Closed | -$315K |
|
|
ARI
1093
Apollo Commercial Real Estate
ARI
$887M
| – | – |
-10,470
| Closed | -$113K |
|
1094
Ashland
ASH
$3.04B
| – | – |
-2,809
| Closed | -$302K |
|
1095
Avantor
AVTR
$7.81B
| – | – |
-75,201
| Closed | -$1.59M |
|
1096
Azenta
AZTA
$1.26B
| – | – |
-11,181
| Closed | -$651K |
|
1097
BioNTech
BNTX
$22.6B
| – | – |
-1,480
| Closed | -$222K |
|
1098
Blackstone
BX
$104B
| – | – |
-3,566
| Closed | -$265K |
|
1099
Calix
CALX
$2.27B
| – | – |
-3,246
| Closed | -$222K |
|
1100
Chemours
CC
$2.59B
| – | – |
-8,575
| Closed | -$263K |
|
Similar funds
MASUI
XL
MSL
CA
TAM
NCM
GC
FNF
Profund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Profund Advisors held 1,192 positions worth $1.62B, up 5% from $1.54B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Profund Advisors withdrew a net $61.1M in Q1 2023, closing 103 positions and reducing 580 holdings. Its most notable exit was Cheniere Energy, an estimated $2.09M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Profund Advisors opened a new position in Twist Bioscience worth $1.2M.
- Profund Advisors's largest Q1 2023 buy was Twist Bioscience: 79,459 shares worth $1.2M.
- Profund Advisors added most to NVIDIA in Q1 2023, an estimated $3.14M increase.
- Profund Advisors's biggest Q1 2023 reduction was AbbVie, cutting an estimated $26.2M.
- Profund Advisors fully exited Cheniere Energy in Q1 2023, selling an estimated $2.09M.
- Profund Advisors's ten largest holdings make up 29% of its $1.62B portfolio in Q1 2023.
- Profund Advisors opened 187 new positions and closed 103 in Q1 2023.
- Profund Advisors's portfolio value rose 5% quarter-over-quarter to $1.62B.
Based on Profund Advisors's 13F filing for Q1 2023, filed 12 May 2023.